Liuling Xiao

2.1k total citations · 1 hit paper
25 papers, 1.6k citations indexed

About

Liuling Xiao is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, Liuling Xiao has authored 25 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in Liuling Xiao's work include Adipose Tissue and Metabolism (8 papers), Adipokines, Inflammation, and Metabolic Diseases (7 papers) and Immune Cell Function and Interaction (5 papers). Liuling Xiao is often cited by papers focused on Adipose Tissue and Metabolism (8 papers), Adipokines, Inflammation, and Metabolic Diseases (7 papers) and Immune Cell Function and Interaction (5 papers). Liuling Xiao collaborates with scholars based in United States, China and South Korea. Liuling Xiao's co-authors include Qing Yi, Jianfei Qian, Qiang Wang, Su Pan, Maojie Yang, Lingqun Ye, Enguang Bi, Lintao Liu, Xingzhe Ma and Brian C. Benicewicz and has published in prestigious journals such as Nature Communications, Blood and Cell Metabolism.

In The Last Decade

Liuling Xiao

23 papers receiving 1.5k citations

Hit Papers

CD36-mediated ferroptosis dampens intratumoral CD8+ T cel... 2021 2026 2022 2024 2021 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liuling Xiao United States 15 483 470 391 365 347 25 1.6k
Qinglin Liu China 20 742 1.5× 504 1.1× 173 0.4× 60 0.2× 297 0.9× 46 1.5k
Herui Wang United States 18 438 0.9× 296 0.6× 100 0.3× 86 0.2× 214 0.6× 67 1.2k
Yunhao Chen China 19 1.4k 2.8× 869 1.8× 125 0.3× 208 0.6× 132 0.4× 38 2.0k
Yanzhu Yang United States 14 516 1.1× 126 0.3× 70 0.2× 126 0.3× 133 0.4× 24 1.4k
Hengyi Chen China 18 466 1.0× 132 0.3× 160 0.4× 288 0.8× 42 0.1× 53 1.2k
Xuhui Ma China 18 805 1.7× 480 1.0× 171 0.4× 91 0.2× 120 0.3× 52 1.3k
Yikai Zhang China 17 421 0.9× 93 0.2× 205 0.5× 60 0.2× 348 1.0× 52 1.4k
Weihua Lan China 16 411 0.9× 200 0.4× 91 0.2× 199 0.5× 78 0.2× 48 915
Gongwei Wu China 15 814 1.7× 474 1.0× 54 0.1× 112 0.3× 86 0.2× 17 1.3k

Countries citing papers authored by Liuling Xiao

Since Specialization
Citations

This map shows the geographic impact of Liuling Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liuling Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liuling Xiao more than expected).

Fields of papers citing papers by Liuling Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liuling Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liuling Xiao. The network helps show where Liuling Xiao may publish in the future.

Co-authorship network of co-authors of Liuling Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Liuling Xiao. A scholar is included among the top collaborators of Liuling Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liuling Xiao. Liuling Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chuanchao, Qiang Wang, Pan Su, et al.. (2025). NPC1 as a novel therapeutic target for induction of pyroptosis in cancers. Biomarker Research. 13(1). 115–115.
2.
Zeng, Ting, Liuling Xiao, Han Wu, et al.. (2025). Adipocyte RNA-binding protein CELF1 promotes beiging of white fat through stabilizing Dio2 mRNA. Nature Communications. 16(1). 7414–7414.
3.
Xiao, Liuling, Rui Duan, Chuanchao Zhang, et al.. (2025). Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8+ T cells activate host CD4+ T cells to control tumors with antigen loss. Nature Cancer. 6(4). 718–735. 2 indexed citations
4.
Xian, Miao, Qiang Wang, Liuling Xiao, et al.. (2024). Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nature Communications. 15(1). 5767–5767. 15 indexed citations
5.
Zhang, Haowei, Wanyu Hu, Liuling Xiao, et al.. (2024). Adipose stem cells control obesity-induced T cell infiltration into adipose tissue. Cell Reports. 43(3). 113963–113963. 14 indexed citations
6.
Xiao, Liuling, et al.. (2024). Lipid peroxidation of immune cells in cancer. Frontiers in Immunology. 14. 1322746–1322746. 18 indexed citations
7.
Qian, Jianfei, Qiang Wang, Liuling Xiao, et al.. (2024). Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers. Journal for ImmunoTherapy of Cancer. 12(1). e008145–e008145. 3 indexed citations
8.
Xiao, Liuling & Qing Yi. (2022). Isolation of adoptively transferred CD8+ T cells in mouse tumor tissues for lipid peroxidation detection. STAR Protocols. 4(1). 101945–101945. 3 indexed citations
9.
Wang, Qiang, Zhijuan Lin, Zhuo Wang, et al.. (2021). RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway. Blood. 139(1). 59–72. 16 indexed citations
10.
Ma, Xingzhe, Liuling Xiao, Lintao Liu, et al.. (2021). CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability. Cell Metabolism. 33(5). 1001–1012.e5. 664 indexed citations breakdown →
11.
Zhao, Bin, Zheng Wan, Hongjian Liu, et al.. (2020). Comprehensive analysis reveals a six-gene signature and associated drugs in mimic inguinal hernia model. Hernia. 24(6). 1211–1219. 3 indexed citations
12.
Huang, Chenglong, Liuling Xiao, Min Xu, et al.. (2020). Chemerin deficiency regulates adipogenesis is depot different through TIMP1. Genes & Diseases. 8(5). 698–708. 15 indexed citations
13.
Liu, Lintao, Enguang Bi, Xingzhe Ma, et al.. (2020). Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9. Nature Communications. 11(1). 5902–5902. 72 indexed citations
14.
Li, Shufen, Yumeng Wang, Xinxin Xie, et al.. (2018). Downregulation of β1,4-galactosyltransferase 5 improves insulin resistance by promoting adipocyte commitment and reducing inflammation. Cell Death and Disease. 9(2). 196–196. 16 indexed citations
15.
Zeng, Qin, Xiaoxiao Sun, Liuling Xiao, et al.. (2018). A Unique Population: Adipose-Resident Regulatory T Cells. Frontiers in Immunology. 9. 2075–2075. 52 indexed citations
16.
Xiao, Liuling, Xuguang Yang, Yuli Lin, et al.. (2015). Large adipocytes function as antigen-presenting cells to activate CD4+ T cells via upregulating MHCII in obesity. International Journal of Obesity. 40(1). 112–120. 82 indexed citations
17.
Liu, Yan, Liuling Xiao, Yue Zhao, et al.. (2015). Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice. Journal of Hepatology. 63(6). 1466–1475. 79 indexed citations
18.
Jayakody, J. R. P., et al.. (2007). NMR Studies of Mass Transport in High-Acid-Content Fuel Cell Membranes Based on Phosphoric Acid and Polybenzimidazole. Journal of The Electrochemical Society. 154(2). B242–B242. 59 indexed citations
19.
Xiao, Liuling, Tushar Jana, Eun‐Seok Choe, et al.. (2005). Synthesis and Characterization of Pyridine‐Based Polybenzimidazoles for High Temperature Polymer Electrolyte Membrane Fuel Cell Applications. Fuel Cells. 5(2). 287–295. 274 indexed citations
20.
Xiao, Liuling, et al.. (2004). SYNTHESIS OF POLY(2, 20-(P-PHENYLENE) 5, 50-BIBENZIMIDAZOLE) (PARA-PBI) AND PHOSPHORIC ACID DOPED MEMBRANES FOR FUEL CELLS. 4. 318–324. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026